Submitted by Anonymous (not verified) on 23 April 2024 - 13:00
Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorised